ReviewBlood transfusion = Trasfusione del sangue2013
Plasma-derived medicinal products in Italy: information sources and flows.
Review in Blood transfusion = Trasfusione del sangue, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed.
- Toward a Sociology of Plasma Products.International journal of social determinants of health and health services · 2024Article
- Shortage of plasma-derived medicinal products: what is next? narrative literature review on its causes and counteracting policies in Italy.Frontiers in pharmacology · 2024Review
- AISF-SIMTI position paper on the appropriate use of albumin in patients with liver cirrhosis: a 2020 update.Blood transfusion = Trasfusione del sangue · 2021Article
- AISF-SIMTI position paper: the appropriate use of albumin in patients with liver cirrhosis.Blood transfusion = Trasfusione del sangue · 2016Article
- Definition of an organisational model for the prevention and reduction of health and social impacts of inherited bleeding disorders.Blood transfusion = Trasfusione del sangue · 2014Article
- The demand for polyvalent immunoglobulins in Italy.Blood transfusion = Trasfusione del sangue · 2013Review
- The evolution of the regulatory framework for the plasma and plasma-derived medicinal products system in Italy.Blood transfusion = Trasfusione del sangue · 2013Review
- Clinical use and the Italian demand for activated prothrombin complex and activated recombinant factor VII concentrates.Blood transfusion = Trasfusione del sangue · 2013Review
- Clinical use and the Italian demand for antithrombin.Blood transfusion = Trasfusione del sangue · 2013Review
- Clinical use and the Italian demand for prothrombin complex concentrates.Blood transfusion = Trasfusione del sangue · 2013Review
- The demand for factor VIII and for factor IX and the toll fractionation product surplus management.Blood transfusion = Trasfusione del sangue · 2013Review
- Public expenditure for plasma-derived and recombinant medicinal products in Italy.Blood transfusion = Trasfusione del sangue · 2013Review
- Plasma and plasma-derived medicinal product self-sufficiency: the Italian case.Blood transfusion = Trasfusione del sangue · 2013Review
- Plasma-derived medicinal products: demand and clinical use.Blood transfusion = Trasfusione del sangue · 2013Article
- The demand for human albumin in Italy.Blood transfusion = Trasfusione del sangue · 2013Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.